Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Efficacy of goldenberry extract in chelated iron overload induced by obesity: Novel safety concept for the treatment of iron overloads diseases

Sherif A. Abdelmottaleb Moussa, Fatma A. A. Ibrahim, Marawan Abd Elbaset, Samir W. Aziz, Noha A. Abdellatif, Atef M. Attia, Sayed A. El Toumy, Josline Y. Salib, Samir A. E. Bashandy.




Abstract
Cited by 0 Articles

Dysregulation of any step implicated in iron (Fe) metabolism in obesity may cause Fe overload. Excess Fe may cause toxic oxygen damage by generating oxygen-free radicals through the Fenton reaction. Furthermore, the three Fe chelating drugs deferiprone, deferoxamine, and deferasirox have many side effects which may limit their use. Therefore, this study intended to treat obesity-induced Fe overload with methanolic extract of goldenberry (GB) fruit with husk on obese rats. Overall, obese rats fed the GB extract showed lower levels of cholesterol, triacylglycerol, total low-density lipoprotein cholesterol, and higher levels of high-density lipoprotein cholesterol than obese rats, along with an improvement in anthropometric characteristics of obese rats. In addition, GB supplementation improved all parameters of Fe status in blood plasma and the trace elements homeostasis in adipose tissues, proving that the GB has a substantial ferric reducing property. GB enhanced the increase in hepcidin concentration in blood plasma and hepcidin gene expression in adipose tissues. In conclusion, there is an ascendant assessment of the role of GB as a natural Fe chelator that inhibits oxidative stress, which plays an essential role in recovering the conformational structure of hemoglobin as a macromolecule.

Key words: Goldenberry, Obesity, iron overload, hemoglobin, hepcidin, adipose tissues






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.